Literature DB >> 16757286

Analysis of the causal factors of prolonged mechanical ventilation after orthotopic liver transplant.

S Faenza1, M S Ravaglia, M Cimatti, A Dante, S Spedicato, A M Morselli Labate.   

Abstract

BACKGROUND: Prolonged mechanical ventilation and the consequently long stay in the intensive care unit (ICU) appear to be important infection risk factors in patients undergoing liver transplant.
METHODS: We analyzed the data relating to 70 liver transplants performed on 67 patients during the past year's activities. For each patient we have considered the presence of preoperative pulmonary alterations, the first radiological result of the postoperative thorax, the PaO(2)/FiO(2) ratio recorded in the peroperative phase immediately after induction of general anesthesia (T0), and arrival at the ICU at the end of the operation (T1). We also considered the enzyme trend (glutamate-oxalacetic transaminase [GOT] and glutamate-pyruvate transaminase [GPT]) recorded every 6 hours for the first 42 hours of the postoperative period (times T1 to T7).
RESULTS: There was an evident correspondence between the values of PaO(2)/FiO(2) < or = 300 ratio at time T1 and the subsequent duration of mechanical ventilation (P = .001). There was also a correlation between the PaO(2)/FiO(2) < or = 300 ratio at time T1 and the trend of the GPT in the first 24 hours postsurgery (P = .021; P = .026; P = .018; P = .048) or GOT trend over the same span of time (P = .027; P = .035; P = .048).
CONCLUSIONS: Graft malfunction as expressed by the enzyme trend affects both the duration of mechanical ventilation and the postoperative PaO(2)/FiO(2) ratios. This metric may be useful to reinforce infection surveillance and to perform an early percutaneous tracheostomy in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757286     DOI: 10.1016/j.transproceed.2006.03.055

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Reversal of severe hepatopulmonary syndrome in chronic hepatic cirrhosis by living donor liver transplantation: report of two cases.

Authors:  Kefei Chen; Bo Li
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

2.  Patient transitions relevant to individuals requiring ongoing ventilatory assistance: a Delphi study.

Authors:  Louise Rose; Robert A Fowler; Roger Goldstein; Sherri Katz; David Leasa; Cheryl Pedersen; Douglas McKim
Journal:  Can Respir J       Date:  2014-05-02       Impact factor: 2.409

3.  Early critical care course in children after liver transplant.

Authors:  Vinay Kukreti; Hani Daoud; Sundeep S Bola; Ram N Singh; Paul Atkison; Alik Kornecki
Journal:  Crit Care Res Pract       Date:  2014-09-25

4.  Factors Associated with Postoperative Prolonged Mechanical Ventilation in Pediatric Liver Transplant Recipients.

Authors:  Olubukola O Nafiu; Katari Carello; Anjana Lal; John Magee; Paul Picton
Journal:  Anesthesiol Res Pract       Date:  2017-07-03

Review 5.  Immediate versus conventional postoperative tracheal extubation for enhanced recovery after liver transplantation: IPTE versus CTE for enhanced recovery after liver transplantation.

Authors:  Jianbo Li; Chengdi Wang; Yuting Jiang; Jiulin Song; Longhao Zhang; Nan Chen; Rui Zhang; Lan Yang; Qin Yao; Li Jiang; Jian Yang; Tao Zhu; Yang Yang; Weimin Li; Lunan Yan; Jiayin Yang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis.

Authors:  Alfonso Wolfango Avolio; Rita Gaspari; Luciana Teofili; Giuseppe Bianco; Giorgia Spinazzola; Paolo Maurizio Soave; Gianfranco Paiano; Alessandra Gioia Francesconi; Andrea Arcangeli; Nicola Nicolotti; Massimo Antonelli
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

7.  Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.

Authors:  Johannes Dillmann; Felix C Popp; Barbara Fillenberg; Florian Zeman; Elke Eggenhofer; Stefan Farkas; Marcus N Scherer; Michael Koller; Edward K Geissler; Robert Deans; Deborah Ladenheim; Martin Loss; Hans J Schlitt; Marc H Dahlke
Journal:  Trials       Date:  2012-11-15       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.